150 related articles for article (PubMed ID: 17022957)
1. Anthracycline glycosides of 2,6-dideoxy-2-fluoro-alpha-L-talopyranose.
Horton D; Khare A
Carbohydr Res; 2006 Nov; 341(16):2631-40. PubMed ID: 17022957
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory activity of four demethoxy fluorinated anthracycline analogs against five human-tumor cell lines.
Horton D; Khare A
Bioorg Med Chem Lett; 2010 Nov; 20(21):6179-81. PubMed ID: 20850305
[TBL] [Abstract][Full Text] [Related]
3. A 5'-(trifluoromethyl)anthracycline glycoside: synthesis of antitumor-active 7-O-(2,6-dideoxy-6,6,6-trifluoro-alpha-L-lyxo-hexopyranosyl) adriamycinone.
Takagi Y; Nakai K; Tsuchiya T; Takeuchi T
J Med Chem; 1996 Apr; 39(8):1582-8. PubMed ID: 8648597
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activity of 7-O-[2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-alpha-L-talopyranosyl]- daunomycinone and -adriamycinone.
Nakai K; Takagi Y; Tsuchiya T
Carbohydr Res; 1999 Mar; 316(1-4):47-57. PubMed ID: 10420587
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of antitumor-active 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
Ok K; Takagi Y; Tsuchiya T; Umezawa S; Umezawa H
Carbohydr Res; 1987 Nov; 169():69-81. PubMed ID: 3427590
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl) daunomycinone derivatives modified at C-3' or C-4'.
Takagi Y; Kobayashi N; Chang MS; Lim GJ; Tsuchiya T
Carbohydr Res; 1998 Feb; 307(3-4):217-32. PubMed ID: 9675364
[TBL] [Abstract][Full Text] [Related]
7. An efficient synthesis of 3-fluoro-5-thio-xylofuranosyl nucleosides of thymine, uracil, and 5-fluorouracil as potential antitumor or/and antiviral agents.
Tsoukala E; Agelis G; Dolinsek J; Botić T; Cencic A; Komiotis D
Bioorg Med Chem; 2007 May; 15(9):3241-7. PubMed ID: 17337193
[TBL] [Abstract][Full Text] [Related]
8. Preparation of 5-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyloxy)-6-hydroxynap htho[2,3- f]quinoline-7,12-dione (FT-Alz), a new-type, potentially antitumor substance with various biological activities.
Tsuchiya T; Takagi Y; Yamada H
Bioorg Med Chem Lett; 2000 Feb; 10(3):203-7. PubMed ID: 10698436
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 7-O-[2,6-dideoxy-2-fluoro-4-O-(3-fluorotetrahydropyran-2-yl)- alpha-L-talopyranosyl]daunomycinone.
Takagi Y; Sohtome H; Tsuchiya T; Umezawa S; Takeuchi T
J Antibiot (Tokyo); 1992 Mar; 45(3):355-62. PubMed ID: 1577663
[TBL] [Abstract][Full Text] [Related]
10. Enantioselective synthesis of (+)-8-hydroxy-8-methylidarubicinone.
Bourghli LM; Stoodley RJ
Bioorg Med Chem; 2004 Jun; 12(11):2863-6. PubMed ID: 15142546
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activities of octyl 2,3,4-tri-O-sulfo-alpha-L-fucopyranosyl-(1-->3)-2,4-di-O-sulfo-alpha-L-fucopyranosyl-(1-->3)-2,4-di-O-sulfo-alpha-L-fucopyranosyl-(1-->3)-2,4-di-O-sulfo-beta-L-fucopyranoside.
Hua Y; Gu G; Du Y
Carbohydr Res; 2004 Mar; 339(4):867-72. PubMed ID: 14980830
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antitumor activity, and cardiac toxicity of new 4-demethoxyanthracyclines.
Penco S; Casazza AM; Franchi G; Barbieri B; Bellini O; Podestà A; Savi G; Pratesi G; Geroni C; Di Marco A; Arcamone F
Cancer Treat Rep; 1983; 67(7-8):665-73. PubMed ID: 6575865
[TBL] [Abstract][Full Text] [Related]
13. Syntheses and antitumor activities of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
Tsuchiya T; Takagi Y; Ok K; Umezawa S; Takeuchi T; Wako N; Umezawa H
J Antibiot (Tokyo); 1986 May; 39(5):731-3. PubMed ID: 3733524
[No Abstract] [Full Text] [Related]
14. Synthesis and antitumor activity of 7-O-(3,4-di-O-acetyl-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)adriamycinone.
Horton D; Priebe W; Turner WR
Carbohydr Res; 1981 Jul; 94(1):11-25. PubMed ID: 7260960
[TBL] [Abstract][Full Text] [Related]
15. Fluoro-ketopyranosyl nucleosides: synthesis and biological evaluation of 3-fluoro-2-keto-beta-D-glucopyranosyl derivatives of N4-benzoyl cytosine.
Manta S; Agelis G; Botić T; Cencic A; Komiotis D
Bioorg Med Chem; 2007 Jan; 15(2):980-7. PubMed ID: 17079149
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of furanosyl alpha-C-glycosides derived from 4-chloro-4-deoxy-alpha-D-galactose and their cytotoxic activities.
Yan L; Dai GF; Yang JL; Liu FW; Liu HM
Bioorg Med Chem Lett; 2007 Jun; 17(12):3454-7. PubMed ID: 17462891
[TBL] [Abstract][Full Text] [Related]
17. Antitumour activity of new semi-synthetic anthracyclines containing fluorotalopyranose.
Umezawa K; Takeuchi T; Komuro K; Nosaka C; Kunimoto S; Tsuchiya T; Takagi Y; Umezawa S; Umezawa H
Drugs Exp Clin Res; 1988; 14(7):429-34. PubMed ID: 3240703
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of 5'-demethyl-5'-trifluoromethyl-daunorubicin and -doxorubicin.
Nakai K; Takagi Y; Ogawa S; Tsuchiya T
Carbohydr Res; 1999 Jul; 320(1-2):8-18. PubMed ID: 10515060
[TBL] [Abstract][Full Text] [Related]
19. A concise synthesis of 3-fluoro-5-thio-xylo- and glucopyranoses, useful precursors towards their corresponding pyranonucleoside derivatives.
Tsoukala E; Manta S; Tzioumaki N; Agelis G; Komiotis D
Carbohydr Res; 2008 May; 343(6):1099-103. PubMed ID: 18313037
[TBL] [Abstract][Full Text] [Related]
20. Oxyhalogenation of glycals for the synthesis of anti-tumor-active 2'-halo daunorubicin analogs.
Horton D; Priebe W
Carbohydr Res; 1985 Feb; 136():391-6. PubMed ID: 4005892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
